Fluorescein Labeled Leukocytes for in vivo Imaging of Retinal Vascular Inflammation and Infiltrating Leukocytes in Laser-Induced Choroidal Neovascularization Model

References

• Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. The Lancet. 2012;379:1728–1738. doi:10.1016/S0140-6736(12)60282-7.
   PubMed Web of Science ®Google Scholar
• Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR. VEGF inhibition study in ocular neovascularization clinical trial group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med. 2004;351:2805–2816. doi:10.1056/NEJMoa042760.
   PubMed Web of Science ®Google Scholar
• Rosenfeld PJ, Shapiro H, Tuomi L, et al. Characteristics of patients losing vision 335 after 2 years of monthly dosing in the phase III ranibizumab clinical trials. Ophthalmology. 2011;118:523–530.
   Google Scholar
• Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular agerelated macular degeneration. N Engl J Med. 2006;355:1419–1431.
   Google Scholar
• Bajwa A, Aman R, Reddy AK. A comprehensive review of diagnostic imaging technologies to evaluate the retina and the optic disk. Int Ophthalmol. 2015;35:733–755.
   PubMed Web of Science ®Google Scholar
• Hua J, Gross N, Schulze B, et al. In vivo imaging of choroidal angiogenesis using fluorescence-labelled cationic liposomes. Mol Vis. 2012;18:1045–1054.
   PubMed Web of Science ®Google Scholar
• Castillo MM, Mowatt G, Elders A, et al. Optical coherence tomography for the monitoring of neovascular age-related macular degeneration: a systematic review. Ophthalmology. 2015;122:399–406.
   PubMed Web of Science ®Google Scholar
• Kauppinen A, Paterno JJ, Blasiak J, Salminen A, Kaarniranta K. Inflammation and its role in age-related macular degeneration. Cell Mol Life Sci. 2016;73:1765–1786.
   PubMed Web of Science ®Google Scholar
• Hollyfield JG, Bonilha VL, Rayborn ME, et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med. 2008; 14:194–198.
   PubMed Web of Science ®Google Scholar
• Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Progress in Retinal and Eye Research. 2001;20:705–732.
   PubMed Web of Science ®Google Scholar
• Perez VL, Caspi RR. Immune mechanisms in inflammatory and degenerative eye disease. Trends in Immunology. 2015;36:354–363.
   PubMed Web of Science ®Google Scholar
• Mathis T, Housset M, Eandi C, et al. Activated monocytes resist elimination by retinal pigment epithelium and downregulate their OTX2 expression via TNF-α. Aging Cell. 2017;16:173–182.
   PubMed Web of Science ®Google Scholar
• Penfold PL, Provis JM, Billson FA. Age-related macular degeneration: ultrastructural studies of the relationship of leucocytes to angiogenesis. Graefe’s Archive for Clinical and Experimental Ophthalmology. 1987;225:70–76.
   PubMed Web of Science ®Google Scholar
• Penfold PL, Killingsworth MC, Sarks SH. Senile macular degeneration: the involvement of immunocompetent cells. Graefe’s Archive for Clinical and Experimental Ophthalmology. 1985;223:69–76.
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu H, Al-Shabrawey M, Caldwell RW, Caldwell RB. Inflammation and diabetic retinal microvascular complications. Journal of Cardiovascular Disease Research. 2011;2:96–103.
   PubMedGoogle Scholar
• Abcouwer SF, Antonetti DA. A role for systemic inflammation in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2013;54:2384.
   PubMed Web of Science ®Google Scholar
• Schroder S, Palinski W, Schmid-Schonbein GW. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol. 1991;139:81–100.
   PubMed Web of Science ®Google Scholar
• Joussen AM, Poulaki V, Le ML, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. Faseb J. 2004;18:1450–1452.
   PubMed Web of Science ®Google Scholar
• Rosenfeld PJ, Shapiro H, Tuomi L, Webster M, Elledge J, Blodi B. Characteristics of patients losing vision after 2 years of monthly dosing in the phase iii ranibizumab clinical trials. Ophthalmology. 2011;118:523–530.
   PubMed Web of Science ®Google Scholar
• Tobe T, Ortega S, Luna JD, et al. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. The American Journal of Pathology. 1998;153:1641–1646.
   PubMed Web of Science ®Google Scholar
• Agrawal, R, Balne PK, Tun SBB, Sia Wey Y, Khandelwal N, Barathi VA. Fluorescent dye labeling of erythrocytes and leukocytes for studying the flow dynamics in mouse retinal circulation. J Vis Exp. 2017;(125):e55495. doi:10.3791/55495.
   Web of Science ®Google Scholar
• Higuchi A, Ohashi K, Kihara S, Walsh K, Ouchi N. Adiponectin suppresses pathological microvessel formation in retina through modulation of tumor necrosis factor-expression. Circulation Research. 2009;104:1058–1065.
   PubMed Web of Science ®Google Scholar
• Dong A, Shen J, Zeng M, Campochiaro PA. Vascular cell-adhesion molecule-1 plays a central role in the proangiogenic effects of oxidative stress. Proceedings of the National Academy of Sciences. 2011;108:14614–14619.
   PubMed Web of Science ®Google Scholar
• Wilkinson-Berka JL, Tan G, Jaworski K, Miller AG. Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology. Circulation Research. 2008;104:124–133.
   PubMed Web of Science ®Google Scholar
• Paques M, Boval B, Richard S, et al. Evaluation of fluorescein-labeled autologous leukocytes for examination of retinal circulation in humans. Current Eye Research. 2000;21:560–565.
   PubMed Web of Science ®Google Scholar
• Yang Y, Kim S, Kim J. Fluorescent dots in fluorescein angiography and fluorescein leukocyte angiography using a scanning laser ophthalmoscope in humans. Ophthalmology. 1997;104:1670–1676.
   PubMed Web of Science ®Google Scholar
• Hossain P, Liversidge J, Cree MJ, et al. In vivo cell tracking by scanning laser ophthalmoscopy: quantification of leukocyte kinetics. Invest Ophthalmol Vis Sci. 1998;39:1879–1887.
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Hiroshiba N, Tsujikawa A, Ogura Y. In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats. Invest Ophthalmol Vis Sci. 1998;39:2190–2194.
   PubMed Web of Science ®Google Scholar
• Sim DA, Chu CJ, Selvam S, et al. A simple method for in vivo labelling of infiltrating leukocytes in the mouse retina using indocyanine green dye. Disease Models & Mechanisms. 2015;8:1479–1487.
   PubMed Web of Science ®Google Scholar
• Nishiwaki H, Ogura Y, Kimura H, Kiryu J, Honda Y. Quantitative evaluation of leukocyte dynamics in retinal microcirculation. Invest Ophthalmol Vis Sci. 1995;36:123–130.
   PubMed Web of Science ®Google Scholar
• Ishida S, Usui T, Yamashiro K, et al. VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci. 2003;44:2155–2162.
   PubMed Web of Science ®Google Scholar
• Joussen AM, Poulaki V, Qin W, et al. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am J Pathol. 2002;160:501–509.
   PubMed Web of Science ®Google Scholar
• Wang J, Xu X, Elliott MH, Zhu M, Le Y, Muller Z. Cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes. 2010;59:2297–2305.
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Khosrof S, Bursell SE, et al. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol. 2000;156:1733–1739.
   PubMed Web of Science ®Google Scholar
• Nakao S, Arima M, Ishikawa K, et al. Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis. Invest Ophthalmol Vis Sci. 2012;53:4323–4328.
   PubMed Web of Science ®Google Scholar
• Vinores SA, Xiao WH, Shen J, Campochiaro PA. TNF-alpha is critical for ischemia-induced leukostasis, but not retinal neovascularization nor VEGF-induced leakage. J Neuroimmunol. 2007;182:73–79.
   PubMed Web of Science ®Google Scholar
• Huang H, Vasilakis P, Zhong X, et al. Parstatin suppresses ocular neovascularization and inflammation. Ophthalmol Vis Sci. 2010;51:5825–5832.
   PubMed Web of Science ®Google Scholar